A randomised, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCI: The CAMPFIRE (CArdiac Muscle Preservation Following Ischemia REperfusion) Study

Bibliographic Details
Main Authors:	Adlam, D, Uren, N, Oldroyd, K, Munir, S, Sharp, A, Zaman, A, Contractor, H, Kiss, R, Edes, I, Jr, ZM, Garcia, MJ, Musialek, P, Tomcsanyi, J, Ptaszynski, P, Nagy, G, Szachniewicz, J, Siegel, L, Shirodaria, C, Selvanayagam, JB, Tulloch, S, Campfire Investigators, Channon, KM
Format:	Conference item
Language:	English
Published:	American Heart Association 2019

Similar Items